CONSTULOSE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Constulose, and what generic alternatives are available?
Constulose is a drug marketed by Actavis Mid Atlantic and is included in one NDA.
The generic ingredient in CONSTULOSE is lactulose. There are twenty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the lactulose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Constulose
A generic version of CONSTULOSE was approved as lactulose by HIKMA on July 3rd, 1995.
Summary for CONSTULOSE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Clinical Trials: | 1 |
Patent Applications: | 3,927 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CONSTULOSE |
Drug Sales Revenues: | Drug sales revenues for CONSTULOSE |
DailyMed Link: | CONSTULOSE at DailyMed |
Recent Clinical Trials for CONSTULOSE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tampa General Hospital | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for CONSTULOSE
US Patents and Regulatory Information for CONSTULOSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Mid Atlantic | CONSTULOSE | lactulose | SOLUTION;ORAL | 070288-001 | Aug 15, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |